Fremont, CA – January 4, 2008 – Optovue, Inc., the first company to introduce a Fourier-domain optical coherence tomography (FD-OCT) system to the US market, today announced the hiring of a new Chief Financial Officer, and a VP of US Sales.

“We welcome the addition of Peggy Fong to Optovue as our CFO”, stated President and CEO Jay Wei. “As we reach milestones on our growth as a company, higher levels of expertise and experience are needed to guide the company. Peggy brings tremendous experience in both the financial and operations area of the corporate environment. With Fortune 500 and Forbes 400 company experience, she brings a level of knowledge that is vital to our continued success and growth.”

Peggy Fong previously held positions of Senior VP of Financial Operations for SYNNEX Corporation, as well as Senior VP of Business Development and General Manager for the Latin America region. SYNNEX is a $6 Billion company. Peggy was also CEO and CFO of Hercules Computer Technology, a $50 million maker of high-end computer graphics cards.

Optovue also welcomes Jeff Keeling in the position of VP of US Sales. “Jeff comes to us with many years in sales management,” noted Jay Wei. “Jeff brings experience in high end diagnostic capital equipment as VP of Western US Sales at OPTOS (~$80 million revenue) and as Director of US Sales for Laser Diagnostic Technologies (LDT).” Mr. Keeling’s previous positions also include management positions at Bausch & Lomb Surgical, as well as Director of Business Development at LDT.

“As our company growth continues to accelerate, we will expand our management team and company resources accordingly. The change from a startup to market leader in fourier-domain OCT during 2007 was tremendous change, and we are transitioning from a small multi-tasking management team, to a larger specialized team. This will allow our team of experienced professionals to focus on our long range growth plan as we grow to the next level as a company,” stated Mr. Wei. “Our original sales team, the distribution plan and marketing strategy were developed and put in place by Paul Kealey. With the addition of Jeff Keeling, Paul will be able to focus on our overall marketing strategy and business development. With the addition of Peggy Fong, I can focus away from finance and operations with confidence.

About Optovue

Optovue, Inc., is a privately-held ophthalmic diagnostic company located in Fremont, California. Optovue was founded in 2003 by ophthalmic industry veterans, including developers of the OCT devices sold by Carl Zeiss Meditec (Humphrey), such as StratusTM and VisanteTM. Optovue has assembled a world-class advisory board comprised of thought leaders in ocular disease diagnosis and treatment, including the original inventors of OCT. Optovue is backed by experienced technology and healthcare venture capital firms and private investors.

Optovue launched the RTVue, the first FDA cleared FD-OCT, at the 2006 Annual Meeting of the American Academy of Ophthalmology. Optovue continues to develop innovative products that will expand the clinical utility of OCT and promote ocular health.
www.optovue.com

Back to News